Prognostic significance of ST-segment elevation during dobutamine stress echocardiography

American Heart Journal
Ana Lucia M ArrudaPatricia A Pellikka

Abstract

Limited data are available concerning the significance of ST-segment elevation during dobutamine stress echocardiography (DSE). The purpose of this study was to assess the prognostic significance of new ST-segment elevation during DSE and its relationship to angiographic severity of coronary artery disease (CAD). From 4240 consecutive patients who had DSE, we identified 134 (3%) patients with new stress-induced ST-segment elevation > or =1 mm in at least two contiguous electrocardiographic leads. Significant CAD was considered as > or =50% diameter obstruction by angiography. Follow-up was obtained for cardiac events. Age was 69 +/- 10 years; 84 (63%) were men. ST-segment elevation developed in the anterior leads in 55 (41%), inferior leads in 100 (75%), and lateral leads in 54 (40%); 56 (42%) had ST elevation in more than one region. Dobutamine stress echocardiography was abnormal in all patients; 115 (86%) had ischemia. Coronary angiography was obtained in 69 (51%) patients. Stenosis was > or =70% diameter in 68 (99%) patients and multivessel in 53 (77%). Follow-up (2.6 +/- 2.8 years) was obtained in all 134 patients. Events occurred in 103 (77%) patients, including death in 53, coronary revascularization in 33, myocardial in...Continue Reading

References

Mar 1, 1996·Journal of the American College of Cardiology·A LombardoA Maseri
Feb 1, 1996·Clinical Cardiology·F G KardarasL P Anthopoulos
Apr 29, 1998·Japanese Circulation Journal·H YamagishiJ Yoshikawa
Jan 5, 1999·The American Journal of Cardiology·M PrevitaliC Cavalotti
Nov 15, 2000·The American Journal of Cardiology·H KawanoH Yasue

❮ Previous
Next ❯

Citations

Dec 23, 2011·The American Journal of Cardiology·Nicolas MansencalOlivier Dubourg
Jul 23, 2013·The American Journal of Cardiology·Jamshid ShiraniAlessandra Brofferio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.